Welcome to Anxiety Disorders Guide
Treatments For General Anxiety Disorder
NMHA MHIC Factsheet: Anxiety Disoders-Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) is characterized by 6 months or more of ... Treatments for GAD include medications and cognitive-behavioral therapy. ...
Generalized Anxiety Disorder - October 1, 2000 - American Family ...
Generalized anxiety disorder treatment algorithm. Psychiatric Annals 1996;26:227-32. Shorr RI, Robin DW. Rational use of benzodiazepines in the elderly. ...
Psych Central: Generalized Anxiety Disorder Treatment
General treatment guidelines for generalized anxiety disorder, including psychotherapy, medications and self-help resources.
Generalized Anxiety Disorder (GAD): Symptoms, Causes, and Treatment
Learn about the symptoms, causes, and treatment of generalized anxiety disorder (GAD). Learn how to manage anxiety and panic.
Generalized Anxiety Disorder: Description, Criteria, Causes ...
Generalized Anxiety Disorder: Description, Criteria, Causes, Symptoms, Treatments and ... Generalized Anxiety Disorder (GAD) is a disorder that little is ...
NIMH: Anxiety Disorders
Five major types of anxiety disorders are:. Generalized Anxiety Disorder ... Effective treatments for anxiety disorders are available, and research is ...
General Anxiety Disorder (GAD) - Treatment - MentalHealthChannel
General Anxiety Disorder (GAD)GAD strikes almost 5000000 people in the US, including children, with vague, intense anxiety and panic.
 |
 |
Treatments For General Anxiety Disorder News
Bipolar symptoms may begin in teen years
NEW YORK (Reuters Health) - The number of teenagers who have experienced mania -- a hallmark of bipolar disorder -- is close to the number of adults estimated to have the mood disorder, suggesting that for many the condition begins during adolescence, according to a new study. "The traditional wisdom has been that mania begins in your 20s and 30s," said Kathleen Ries Merikangas, the study's lead ...
Read more...Data from Study of Elderly Depressed Patients are Reported for Investigational Compound Lu AA21004 on Symptoms of ...
PHILADELPHIA, May 8, 2012 /PRNewswire/ -- Today, H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Global Research & Development Center Inc., U.S., presented data which demonstrated significant improvements ...
Read more...Panel suggests DSM-5 psychiatry manual drops two disorders, keeps new autism definition
Attenuated psychosis syndrome and mixed anxiety depressive disorder should be removed because there were faults with their definitions
Read more...Priority Health - Treating anxiety naturally
This viewer question came from Michelle: "Are there any natural ways to reduce anxiety ?"
Read more...Autism Speaks plays key roles at 2012 International Meeting for Autism Research
Autism Speaks is a major sponsor and participant in IMFAR 2012. The Autism Treatment Network presentations include the technology demonstration "Development of a Training Video to Teach Best Practices for Delivering An ASD Diagnosis to Families"; and oral presentation "Spotting Children with Autism in Early Childcare Settings: Workshops to increase knowledge and confidence in Autism for Early ...
Read more...Dainippon Sumitomo Pharma Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase ...
Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression .
Read more...PTSD vies for med pot relief
PHOENIX -- Arizonans who say they suffer from post-traumatic stress disorder are hoping to get the same medical options as those with glaucoma or seizures: the right to use marijuana for medical purposes.
Read more...